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Figure 1. (A). Skin phenotypes of a RDEB mouse after birth (DO), on D7 and D16 demonstrating amelioration of hemorrhagic blisters following a single USSC
intrahepatic treatment. (B). Kaplan-Meier survival curves of the RDEB mice that received PBS, a single intrahepatic USSC and repeated intrahepatic USSC injections.
(C). H&E staining of the paws of RDEB mice on different days following a single USSC intrahepatic injection.
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Background: RDEB is a severe inherited skin blistering dis-
ease caused by mutations in the COL7A1 gene that encodes
type VII collagen (C7), a major component in the anchoring
ﬁbrils at the basement membrane. Allogeneic stem cell
transplantation in both experimental animals and human
subjects with RDEB resulted in increased C7 deposition and
alleviation of the blistering phenotype in some recipients
(Kiuru/Cairo/Christiano et al 2011). However, there was no
distinct anchoring ﬁbril formation in the recipient skin and
the effective cell types that contribute to the regeneration in
RDEB skin remain to be identiﬁed. Our previous studies
demonstrated that CB-derived USSCs express C7 and
promote epithelialization and wound closure in a murine
wound healing model (Liao/Cairo et al Cell Transplant 2014).
Methods: CB-derived USSCs were labeled with GFP/Luc
reporter gene and injected in newborn col7a1-/- (RDEB) mice
without immunosuppression. The migration of USSCs was
determined by bioluminescent imaging (BLI) of RDEBmice as
well as excised internal organs.
Results: Asingle intra-hepatic injection ofUSSCs (0.2 x106) in
newborn RDEB mice arrested the blistering phenotype and
signiﬁcantly enhanced the median survival to 8 days (n¼21),
as compared to 2 days in PBS injected animals (n¼18)
(P<0.0001) (Figure 1). About 30% of the USSC-treated mice
lived beyond2weeks of life span and onemouse lived for four
weeks. Histological analysis on the footpad skin of the RDEB
mice demonstrated that the percentage of the skinwith intact
epidermis-dermis attachment was signiﬁcantly improved
from20% 6% onD0 to 70% 12% on day 5, afterwards after a
single intra-hepatic USSC injection. A second USSC intra-
hepatic injection further elongated the median life span (16
days, n¼ 18, P<0.0001) (Figure 1). Remarkably, twomice that
received repeated injections survivedmore than12weeks. BLI
of the RDEB mice following USSC injection further
demonstrated that USSCs rapidly went into circulation afterintra-hepatic injection and did not result in detectable
retention in heart, kidney, and spleen. Immunocytochemical
analysis revealed speciﬁc engraftment of USSCs in
gastrointestinal tract and the dermis and hair follicles of the
skin, suggesting a speciﬁc migration of USSCs toward the
sites of blisters. USSC injection also enhanced the expression
of C7 in the recipient skin and electron microscopy revealed
a partial restoration of anchoring ﬁbrils in skin biopsies
from the USSC-treated RDEB mice. We also demonstrated
that USSCs treatment induced an inﬁltration of
macrophages with a regenerative “M2” phenotype.
Conclusion: Our data suggest that HUCB-derived USSCs
improved the RDEB mucocutaneous manifestations in
col7a1-/- mice through multiple mechanisms. This study
warrants future clinical investigation of USSCs as a novel and
universal allogeneic stem cell donor source in selected
patients with RDEB.329
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Ex vivo expansion of human peripheral blood (PB) gamma
delta T cells, speciﬁcally the Vg9Vd2 subset, using aminobi-
sphosphonates (NBPs) has been extensively studied. Reports
suggest that NPBs can also stimulate human umbilical cord
blood (CB) gamma delta T cell proliferation ex vivo. However,
as CB gamma delta T cells are not well described in the
literature, we conducted a detailed comparison of CB gamma
Table
Distribution of BCG scar positivity and presence of INH prophylaxis with
respect to TST values
Autologous HSCT Allogeneic HSCT
N¼320 N¼272
TST value Positive BCG scar/INH
prophylaxis/total # of
patients
Positive BCG scar/INH
prophylaxis/total # of
patients
0-4, 9 mm 68/13 /153 70/10/ 137
5- 9, 9 mm 21/14/ 37 24/16/ 33
10- 19, 9 mm 53/56/ 87 31/29/ 57
‡ 20 mm 5/9/ 17 7/7/ 8
data not available 26 37
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function to PB gamma delta T cells when culturing cells with
the NBP, Zometa (zoledronic acid), and IL-2. Fourteen days in
culture resulted in signiﬁcant fold increase in the prolifera-
tion of gamma delta Tcells and in the percent of lymphocytes
in both sample types. PB gamma delta T cells proliferated
more robustly than CB with a 288.60 versus 21.32 fold
increase, respectively. Additionally, in freshly isolated
samples, CB gamma delta T cells comprised an average of
1.404% of the lymphocyte population, which was similar to
PB gamma delta T cells, with an average of 2.319%. However,
by day 14, PB gamma delta T cells increased to 70.15% of
lymphocytes whereas CB gamma delta T cells increased to
12.49%. Phenotypically, we also examined TCRg9 and TCRd2
expression and found that the TCRg9d2 was a common clone
in freshly isolated PB gamma delta T cells, which predomi-
nated after 14 days in culture. However, while the TCRg9d2
variant was present in CB gamma delta T cells, it was low
before and after culture, suggesting that Zometa may not
stimulate gamma delta T cells in CB the same as PB. The
memory subsets of freshly isolated gamma delta T cells were
similar for CB and PB. Yet following culture, PB gamma delta
T cells were mostly CD45RO+ memory cells, speciﬁcally
effector or central memory subsets, with signiﬁcantly fewer
CD45RA+ naïve cells, whereas more CB gamma delta T cells
were of the intermediate CD45RA+CD45RO+ naïve subset. In
addition, we also observed thatmemory status corresponded
with the TCR variant; more Vg9 and Vd2 cells were memory
cells and Vd1 cells weremostly naïve. Functionally, PB and CB
gamma delta T cells had distinct cytokine secretion proﬁles
both before and after culture. PB gamma delta Tcells secreted
more IFNg and TNFa after culture, while CB gamma delta T
cells secreted more IL-10 and RANTES. As limited TCRgd
phenotypic reagents are available, we developed a single cell
PCR assay for genotypic analysis of the TCRgd repertoire. PCR
analysis suggests that the TCRgd repertoire of freshly isolated
cells is diverse in both samples types, with more variation
among the CB gamma delta T cells, while TCRg9d2 is most
prevalent in PB. Further analysis of the variant subsets is
warranted and may give insight into how each of these
receptor pairings affects gamma delta T cell function.SUPPORTIVE CARE330
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Turkey is a country with intermediate tuberculosis (TB)
prevalence (24 cases per 100,000 population) where BCG
vaccination is mandatory. Immunocompromised patients are
at risk for TB infection. However, tuberculin skin test (TST)
has limitations in immunocompromised patients while
diagnosing latent TB infection (LTBI) and commencing
isoniazid (INH) chemoprophylaxis. After 2000 consensus
statements recommended INH prophylaxis in higher risk
patients with a cut-off TST value of 5 mm. This retrospectivestudy was conducted to determine the frequency of TB in
HSCT recipients and the role of chemoprophylaxis with
different cut-off values of TST (<5 mm, 5 to 10 mm, 10 to 20
mm, and 20 mm) in a region with intermediate TB
prevalence.
Patients and Methods: Five hundred and ninety two
patients [320 (54 %) autologous and 272 (46 %) allogeneic]
transplanted at our center between September 2003 and July
2014 and survived for 100 days post-transplantation were
included. The median age was 51 years-old (range 16-71) in
autologous and 29 years-old (range 15-64) in allogeneic
HSCT recipients. The decision to initiate INH prophylaxis was
usually based on universal guidelines howevermodiﬁcations
were also made at the discretion of the pulmonologist
responsible for the pre-transplantation consultation or the
new released guidelines. Anergy was deﬁned as any reaction
size of 0 to 2 mm in diameter.
Results: BCG scar datawas available in 148 of 320 autologous
(46.3 %) and 133 of 272 (48.9 %) allogeneic HSCT recipients.
Distribution of positive BCG scar and INH prophylaxis with
respect to TST values are given in table. Anergy was detected
in 141 (44.1 %) of autologous and 124 (45.7 %) of allogeneic
HSCT recipients. Positive BCG vaccination scar data was
available in 47% of anergic patients. Ninety-two (28.8%) of
autologous and 64 (23.5 %) of allogeneic HSCT recipients
received INH prophylaxis. None of the allogeneic HSCT
recipients and 1 in 320 (0.3 %) patients in autologous HSCT
developed TB. This patient was TST anergic prior to
transplantation and was not on chemoprophylaxis.
Conclusion: Our data showed low frequency of TB after
HSCT despite variable chemoprophylaxis practices. Recent
guidelines recommended reduction of TST threshold to 5
mm in higher risk patients. However our results suggest that
these general guidelines do not apply to all patients and all
regions.331
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Background: Early detection and treatment of fungal
sinusitis is critical in the successful treatment of these
